Panel Discussion: Antibody Discovery
Overview
There has been a large acceleration in the number of antibody-based therapeutics being developed for a range of diseases, including infectious diseases, cancer and Alzheimer’s.
Antibody discovery is a crucial step in developing antibody therapeutics. Large numbers of antibodies are screened and assessed for their therapeutic potential. These programs rely on high-throughput technologies to quickly identify candidates.
In this Panel Discussion, experts in antibody discovery discuss how the field has developed over the past decade, the technologies which are driving those developments, and what is predicted for the future.
- Document type: Webinar
- Watch time: 55 minutes
Key Takeaways
Listen out for expert views on:
- The high-throughput technologies being utilized for antibody discovery
- How artificial intelligence (AI) is being used in discovery programs
- What the future holds for antibody therapeutics
Webinar Speakers
Jamie Spangler
Assistant Professor and Principal Investigator
Johns Hopkins University, United States
Lydia Fenn
Scientist
LifeArc, United Kingdom
Tim Jenkins
Assistant Professor
Denmark Technical University, Denmark
Nicola Bevan
Manager of Cell Imaging Applications
Sartorius, United Kingdom
